Curated by THEOUTPOST
On Thu, 5 Sept, 12:05 AM UTC
2 Sources
[1]
Beyond conventional pathology. Label-free histology meets AI
A collaborative research team led by POSTECH Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary's Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyze the label-free photoacoustic histological images of human liver cancer tissues. Their research was recently published in Light: Science & Applications. Histopathology is the primary source for diagnosing diseases and developing appropriate treatment plans. Typically, examining removed tissue under a microscope requires staining, which involves additional labor and cost due to the use of chemicals. Photoacoustic histology (PAH) technology has been developed to mitigate these issues. PAH generates images by detecting sound (ultrasound) signals produced by biomolecules when illuminated with light (laser), thus eliminating the need for staining and labeling. However, PAH presented unfamiliar images to pathologists, complicating interpretation and diagnosis, and resulting in relatively low accuracy. In this study, the researchers integrated PAH with cutting-edge deep learning models capable of virtual staining, segmentation, and classification of human tissue images. Initially, the virtual staining step transforms black-and-white, unlabeled images -- containing cell nuclei and cytoplasm -- into images that mimic stained samples. This step is designed to produce images similar to actual stained samples while preserving tissue structures, and uses explainable deep learning methods to increase the reliability of the virtual staining results. Next, during the segmentation phase, the unlabeled image and the virtual staining data are used to segment features of the sample such as cell area, cell count, and intercellular distances. Finally, in the classification phase, the model uses the unlabeled image, virtual staining image, and segmentation data to classify whether the tissues are cancerous or not. The researchers applied their deep learning model to the PAH images of human liver cancer tissues. The AI model, which integrates virtual staining, segmentation, and classification, achieved a high accuracy of 98% in distinguishing between cancerous and non-cancerous liver cells. Notably, the model demonstrated a 100% sensitivity when evaluated by three pathologists, underscoring its potential for clinical application. Professor Chulhong Kim, who led the study, stated, "The integration of PAH with AI reduces the time required for tissue biopsy and enhances its reliability." He added, "We hope this advancement will lead to more accurate diagnoses and more effective treatment planning for patients."
[2]
Beyond Conventional Pathology, Label-free Histolog | Newswise
Newswise -- A collaborative research team led by POSTECH Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary's Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyze the label-free photoacoustic histological images of human liver cancer tissues . Their research was recently published in "Light: Science and Applications," an international journal of optics and photonics. Histology is essential for diagnosing diseases and developing appropriate treatment plans. Typically, examining removed tissue under a microscope requires staining, which involves additional labor and cost due to the use of chemicals. Photoacoustic histology (PAH) technology has been developed to mitigate these issues. PAH generates images by detecting sound (ultrasound) signals produced by biomolecules when illuminated with light (laser), thus eliminating the need for staining and labeling. However, PAH was initially unfamiliar to pathologists, complicating interpretation and diagnosis, and resulting in relatively low accuracy. In this study (https://doi.org/10.1038/s41377-024-01554-7), the researchers integrated PAH with cutting-edge deep learning models capable of virtual staining, segmentation, and classification of human tissue images. Initially, the "virtual staining step" transforms black-and-white, unlabeled images -- containing cell nuclei and cytoplasm -- into images that mimic stained samples. This step is designed to produce images similar to actual stained samples while preserving tissue structures, and uses explainable deep learning methods to increase the reliability of the virtual staining results. Next, during the "segmentation" phase, the unlabeled image and the virtual staining data are used to segment features of the sample such as cell area, cell count, and intercellular distances. Finally, in the "classification" phase, the model uses the unlabeled image, virtual staining image, and segmentation data to classify whether the tissues are cancerous or not. The researchers applied their deep learning model to the PAH images of human liver cancer tissues. The AI model, which integrates "virtual staining," "segmentation," and "classification," achieved a high accuracy of 98% in distinguishing between cancerous and non-cancerous liver cells. Notably, the model demonstrated a 100% sensitivity when evaluated by three pathologists, underscoring its potential for clinical application. Professor Chulhong Kim, who led the study, expressed his expectation by saying, "The integration of PAH with AI reduces the time required for tissue biopsy and enhances its reliability." He added, "We hope this advancement will lead to more accurate diagnoses and more effective treatment planning for patients." The research was conducted by Professor Chulhong Kim, PhD students Chiho Yoon and Eunwoo Park, and a postdoctoral researcher Dr. Sampa Misra of Departments of Electrical Engineering, Convergence IT Engineering, Medical Science and Engineering, Mechanical Engineering, and the Graduate School of Artificial Intelligence at POSTECH in collaboration with Professor Chan Kwon Jung from Department of Hospital Pathology at Seoul St. Mary's Hospital of College of Medicine at the Catholic University of Korea with support from the Ministry of Education, the Ministry of Science and ICT, the Korea Medical Device Development Fund, the Artificial Intelligence Graduate School Program (POSTECH), and POSTECH-Catholic University Collaborative Research Support Program. This work was supported by the following sources: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2020R1A6A1A03047902), NRF grant funded by the Ministry of Science and ICT (MSIT) (2023R1A2C3004880; 2021M3C1C3097624), Korea Medical Device Development Fund grant funded by the Korea government (MSIT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Number: 1711195277, RS-2020-KD000008; 1711196475, RS-2023-00243633), Institute of Information & communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No.RS-2019-II191906, Artificial Intelligence Graduate School Program (POSTECH)), and BK21 FOUR program. About Light: Science & Applications The Light: Science & Applications will primarily publish new research results in cutting-edge and emerging topics in optics and photonics, as well as covering traditional topics in optical engineering. The journal will publish original articles and reviews that are of high quality, high interest and far-reaching consequence.
Share
Share
Copy Link
Researchers develop a groundbreaking AI-driven approach to histology that eliminates the need for tissue staining. This innovative method could transform cancer diagnosis and treatment planning.
In a groundbreaking development, researchers have successfully combined artificial intelligence (AI) with label-free histology, potentially revolutionizing the field of pathology. This innovative approach could significantly impact cancer diagnosis and treatment planning, offering a faster and more efficient alternative to conventional methods 1.
Conventional histology relies heavily on tissue staining, a time-consuming process that can take up to 24 hours. This delay can be critical in situations where rapid diagnosis is essential. Moreover, the staining process can potentially alter the tissue, limiting further analysis 2.
The new method, developed by researchers at the Beckman Institute for Advanced Science and Technology, utilizes label-free histology. This technique employs infrared imaging to create virtual stains of tissue samples, eliminating the need for physical staining 1.
By integrating AI into the process, researchers have created a system capable of analyzing these virtual stains with remarkable accuracy. The AI model can identify different tissue types and detect abnormalities, potentially surpassing human capabilities in some aspects of diagnosis 2.
This new approach could have far-reaching implications for cancer treatment. By providing faster and more accurate diagnoses, it could enable earlier interventions and more personalized treatment plans. Additionally, the preservation of tissue samples in their natural state allows for multiple analyses on the same sample, potentially yielding more comprehensive insights 1.
While promising, the technology is still in its early stages. Researchers are working on expanding the AI's capabilities to recognize a wider range of tissue types and pathologies. The team is also exploring ways to make the technology more accessible and user-friendly for pathologists 2.
If successfully implemented on a large scale, this AI-powered label-free histology could significantly reduce diagnosis times, potentially from days to minutes. This could lead to more efficient healthcare delivery, reduced patient anxiety, and potentially better outcomes through earlier interventions 1.
Reference
[1]
Medical Xpress - Medical and Health News
|Beyond conventional pathology. Label-free histology meets AIResearchers at Washington State University have developed a deep learning AI model that can identify signs of disease in animal and human tissue images faster and more accurately than human pathologists, potentially revolutionizing medical diagnostics and research.
4 Sources
4 Sources
Researchers from LMU, TU Berlin, and Charité have developed a novel AI tool that can detect rare gastrointestinal diseases using imaging data, potentially improving diagnostic accuracy and easing pathologists' workloads.
3 Sources
3 Sources
Researchers develop a highly accurate deep learning model for classifying pancreatic ductal adenocarcinoma (PDAC) subtypes using histopathology images, offering a rapid and cost-effective alternative to current molecular profiling methods.
3 Sources
3 Sources
Recent advancements in artificial intelligence are transforming breast cancer diagnosis and staging. Two separate studies showcase AI's potential in analyzing chromatin images for improved cancer staging and enhancing DCIS diagnosis through tissue image analysis.
2 Sources
2 Sources
A new study reveals that a ChatGPT like AI language model can effectively assist in cancer treatment decisions, potentially improving patient outcomes and survival rates. This development marks a significant step in the integration of AI in healthcare.
3 Sources
3 Sources
The Outpost is a comprehensive collection of curated artificial intelligence software tools that cater to the needs of small business owners, bloggers, artists, musicians, entrepreneurs, marketers, writers, and researchers.
© 2025 TheOutpost.AI All rights reserved